Øystein Fluge
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Lymphoma Diagnosis and Treatment 25
-
- Fibromyalgia and Chronic Fatigue Syndrome Research 24
Øystein Fluge
86 papers receiving 13.6k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 6.1k
- Oncology 6.4k
- Pathology and Forensic Medicine 1.8k
- Molecular Biology 6.5k
- Genetics 1.7k
Countries citing papers authored by Øystein Fluge
This map shows the geographic impact of Øystein Fluge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein Fluge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein Fluge more than expected).
Fields of papers citing papers by Øystein Fluge
This network shows the impact of papers produced by Øystein Fluge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein Fluge. The network helps show where Øystein Fluge may publish in the future.
Co-authors
The 25 scholars most cited alongside Øystein Fluge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 71 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 34 | |
| 10 | 2020 | 13 | |
| 11 | 2019 | 18 | |
| 12 | 2016 | 7 | |
| 13 | 2014 | 18 | |
| 14 | 2014 | 79 | |
| 15 | 2012 | 86 | |
| 16 | 2009 | 7 | |
| 17 | 2009 | 16 | |
| 18 | 2008 | 18 | |
| 19 | Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. | 2001 | 264 |
| 20 | 1998 | 15 |
About Øystein Fluge
Øystein Fluge is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health, Neurology, Oncology and Complementary and Manual Therapy, having authored 91 papers that have together received 13.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (25 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Cancer survivorship and care (7 papers), Viral-associated cancers and disorders (6 papers), Glioma Diagnosis and Treatment (6 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Meningioma and schwannoma management (5 papers). The work is most often cited by research in Cancer Research (6.1k citations), Oncology (6.4k citations), Pathology and Forensic Medicine (1.8k citations), Molecular Biology (6.5k citations) and Genetics (1.7k citations). Øystein Fluge has collaborated with scholars based in Norway, Denmark and Sweden. Frequent co-authors include Lars A. Akslen, Hilde Johnsen, Per Eystein Lønning, Patrick O. Brown, Stefanie S. Jeffrey, Anne‐Lise Børresen‐Dale, Michael B. Eisen, Christian A. Rees, Charles M. Perou and David Botstein. Their work appears in journals such as PLoS ONE, Blood, Haematologica, British Journal of Cancer and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.